Data from Phase 2 BEHOLD study of UBX1325 in DME patients-Unity Biotechnology
Ophthalmology Times - 12-Aug-2022Statistically significant treatment effect for both BCVA and CST was seen at both 12 and 18 weeks
Join the club for FREE to access the whole archive and other member benefits.
Director of Clinical Research at Sierra Eye Associates
Dr. Khanani is a fellowship trained vitreo-retinal specialist and is certified by The American Board of Ophthalmology. He graduated magna cum laude in chemistry from Washington University in St. Louis with a Bachelors and Masters degree. While at Washington University, Dr. Khanani was honored with The Howard Hughes Medical Institute Research Award.
Dr. Khanani then returned home to Texas and obtained his medical degree at Texas Tech School of Medicine where he received several prestigious research awards. After finishing his internship at Baylor College of Medicine, Dr. Khanani completed his residency in Ophthalmology at Texas Tech School of Medicine. During his residency, he was unanimously elected as Chief Resident.
Dr. Khanani attended The University of Texas – Southwestern Medical Center in Dallas for a two-year fellowship in the medical and surgical treatment of vitreo-retinal diseases.
Dr. Khanani has received numerous awards of distinction including The Patients’ Choice Award and The Compassionate Doctor Recognition Award. He has also been consistently named one of America’s Top Ophthalmologists and has also been included in an edition of The Leading Physicians of the World publication.
Visit website: https://sierraeyeassociates.com/doctors/arshad-khanani-m-d-m-a/
See also: Sierra Eye Associates - Provides expert eye care in Northern Nevada
Details last updated 05-Oct-2022
Statistically significant treatment effect for both BCVA and CST was seen at both 12 and 18 weeks